NuVasive (NASDAQ:NUVA) is an innovative player in the spine surgery devices market offering more than 80 unique products. The company's Maximum Access Surgery ("MAS") for lateral spine fusion provides highly differentiated solution with fully integrated nerve monitoring and customizable exposure. The majority of NUVA's revenues are derived from the sale of disposables, implants and fixation devices designed to address a variety of pathologies. I believe that a few of NUVA's recent innovative launches that were named on the "100 Minimally Invasive Orthopedic & Spine Devices to Know" list, such as ALIF ACR, CoRoent XL and XLIF Decade Plate, coupled with its product offerings relating to procedures in the cervical spine as well as in the area...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|